User: Guest  Login
Sort by:
and:
More ...

Kessel, K. A.;Kessel, C.;Vogel, M. M. E.;Bier, H.;Biedermann, T.;Friess, H.;Herschbach, P.;von Eisenhart-Rothe, R.;Meyer, B.;Kiechle, M.;Keller, U.;Peschel, C.;Schmid, R.;Schwaiger, M.;Combs, S. E.
Cancer Clinical Trials - survey evaluating patient participation and attitude in an Oncology Center
Radiother Oncol
2018
127
S50-S50

More ...

Kornberg, A.;Witt, U.;Kornberg, J.;Mueller, K.;Friess, H.;Thrum, K.
Patients with 18F-FDG PET-positive hepatocellular carcinoma and elevated values of alpha-fetoprotein and C-reactive protein have an extraordinary high risk of tumor recurrence following liver transplantation
J Hepatol
2018
68
S382-S383

More ...

Klompmaker, Sjors;van Hilst, Jony;Gerritsen, Sarah L;Adham, Mustapha;Teresa Albiol Quer, M;Bassi, Claudio;Berrevoet, Frederik;Boggi, Ugo;Busch, Olivier R;Cesaretti, Manuela;Dalla Valle, Raffaele;Darnis, Benjamin;De Pastena, Matteo;Del Chiaro, Marco;Grützmann, Robert;Diener, Markus K;Dumitrascu, Traian;Friess, Helmut;Ivanecz, Arpad;Karayiannakis, Anastasios;Fusai, Giuseppe K;Labori, Knut J;Lombardo, Carlo;López-Ben, Santiago;Mabrut, Jean-Yves;Niesen, Willem;Pardo, Fernando;Perinel, Julie;Popescu, Irinel;Roeyen, Geert;Sauvanet, Alain;Prasad, Raj;Sturesson, Christian;Lesurtel, Mickael;Kleeff, Jörg;Salvia, Roberto;Besselink, Marc G
Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study.
Ann Surg Oncol
2018
25
5
1440-1447

More ...

Schorn, Stephan;Nitsche, Ulrich;Demir, Ihsan Ekin;Scheufele, Florian;Tieftrunk, Elke;Schirren, Rebekka;Klauss, Sarah;Sargut, Mine;Ceyhan, Güralp Onur;Friess, Helmut
The impact of surgically placed, intraperitoneal drainage on morbidity and mortality after pancreas resection- A systematic review & meta-analysis.
Pancreatology
2018
18
3
334-345

More ...

Muench, S.;Pigorsch, S.;Feith, M.;Slotta-Huspenina, J.;Weichert, W.;Friess, H.;Combs, S.;Habermehl, D.
Comparison of neoadjuvant chemoradiation with carboplatin/paclitaxel or CDDP/5-FU for esophageal SCC
Radiother Oncol
2018
127
S768-S769

More ...

Molina-Montes, E;Gomez-Rubio, P;Márquez, M;Rava, M;Löhr, M;Michalski, C W;Molero, X;Farré, A;Perea, J;Greenhalf, W;Ilzarbe, L;O'Rorke, M;Tardón, A;Gress, T;Barberá, V M;Crnogorac-Jurcevic, T;Domínguez-Muñoz, E;Muñoz-Bellvís, L;Balsells, J;Costello, E;Huang, J;Iglesias, M;Kleeff, J;Kong, Bo;Mora, J;Murray, L;O'Driscoll, D;Poves, I;Scarpa, A;Ye, W;Hidalgo, M;Sharp, L;Carrato, A;Real, F X;Malats, N
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives.
Int J Epidemiol
2018
47
2
473-483

More ...

Schorn, S;Demir, I E;Samm, N;Scheufele, F;Calavrezos, L;Sargut, M;Schirren, R M;Friess, H;Ceyhan, G O
Meta-analysis of the impact of neoadjuvant therapy on patterns of recurrence in pancreatic ductal adenocarcinoma.
BJS Open
2018
2
2
52-61

More ...

Keane, M G;Shamali, A;Nilsson, L N;Antila, A;Millastre Bocos, J;Marijinissen Van Zanten, M;Verdejo Gil, C;Maisonneuve, P;Vaalavuo, Y;Hoskins, T;Robinson, S;Ceyhan, G O;Abu Hilal, M;Pereira, S P;Laukkarinen, J;del Chiaro, M
Risk of malignancy in resected pancreatic mucinous cystic neoplasms.
Br J Surg
2018
105
4
439-446

More ...

Buhner, Sabine;Hahne, Hannes;Hartwig, Kerstin;Li, Qin;Vignali, Sheila;Ostertag, Daniela;Meng, Chen;Hörmannsperger, Gabriele;Braak, Breg;Pehl, Christian;Frieling, Thomas;Barbara, Giovanni;De Giorgio, Roberto;Demir, Ihsan Ekin;Ceyhan, Güralp Onur;Zeller, Florian;Boeckxstaens, Guy;Haller, Dirk;Kuster, Bernhard;Schemann, Michael
Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
PLoS ONE
2018
13
3

More ...

Zhang, Bin;Deng, Chao;Wang, Lei;Zhou, Fan;Zhang, Shu;Kang, Wei;Zhan, Ping;Chen, Juan;Shen, Shanshan;Guo, Huimin;Zhang, Ming;Wang, Yi;Zhang, Feng;Zhang, Wei;Xiao, Jiangqiang;Kong, Bo;Friess, Helmut;Zhuge, Yuzheng;Yan, Hongli;Zou, Xiaoping
Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Mol Carcinog
2018
57
2
201-215